The online invitation survey was conducted among 6,500 pet owners from around the world, 1,000 of whom were based in the UK.
Whilst the survey didn't glean any further information about the nature of the infections, such as what percent of them were endoparasites versus ectoparasites, it did reveal that 61% of respondents said their pet experienced discomfort or illness, 39% said they showed behavioural changes and 38% reported that it made them feel anxious.
However, 38% see a parasite infection as not serious or just slightly serious.
Seventy per cent of owners said they get their parasite information from vets, compared to 43% from the internet.
Forty-five per cent use prescription treatments and 40% use vet-administered treatments in a clinic.
According to the company, 71% of UK pet owners said they would like clearer guidance on parasite protection, yet 35% have not been informed about parasite risks in their area by their vet.
Ian Wright MRCVS, Chairman/Director of ESCCAP (European Scientific Counsel Companion Animal Parasites), said: "It has never been more important to be aware of parasites and the risk to companion animals – the increased movement of pets and people, as well as climate change, has fuelled a rapid shift in the distribution of parasites and their proximity to pets.
"Pets can carry parasites which affect animal and human health - although there are familiar types, such as fleas – we need to be vigilant for unexpected parasites moving into new countries and regions.
"With simple precautions and preventative measures, we can minimise the risk of diseases they may bring, and continue to enjoy the wonderful benefits of pet ownership."
This allows patients to try the drug at lower cost, before progressing to the 30ml bottle for ongoing treatment.
Samantha Taylor, RCVS Recognised Specialist in Feline Medicine said: “It’s great we now have the option to prescribe the smaller 12ML bottle for starting cats on Senvelgo, as it means we don’t have to worry about wasting a 30ml bottle if it becomes evident that the cat requires insulin in the first couple of weeks.”
https://senvelgo.co.uk
The company says the two main benefits of the liquid formulation are precise dosing and ease of administration.
Vetmedin oral solution comes with a kg-bodyweight calibrated syringe to make it easy to give the preferred dose of 0.25 mg/kg twice daily to the nearest 0.5 kg bodyweight.
The maximum syringe volume is for a 12 kg dog.
The solution has a sweet taste to make it palatable and Boehringer says it is also ideal for dogs that need dental work but require treatment for their heart disease before general anaesthesia.
These dogs might struggle to eat chewable tablets due to oral discomfort, so a liquid treatment might be a better option.
The company highlights the EPIC1 and PROTECT2 studies which showed that Vetmedin delays the onset of CHF for dogs in the asymptomatic stage of heart disease and improves both the quality and length of life for dogs with MVD and DCM.
Vetmedin oral solution comes as a 50 ml bottle (each bottle lasts a 5 kg dog approximately 30 days), doesn't need to be refrigerated, has an 8-week shelf life once opened, and a 2-year shelf life as packaged.
VetMedin oral solution is now available to order from wholesalers.
References
The new product is being sold through e-retailers including Pet Drugs Online, Animed and Pets at Home.
Frontpro is claimed to kill fleas within 8 hours and protect dogs from fleas and ticks for one month.
It is suitable for all breeds aged eight weeks or older (weighing two kilograms or more) and can be given with or without food.
A company spokesperson said: "Boehringer Ingelheim is committed to expanding access to high-quality parasite prevention for dogs, which is why we’re proud to introduce an effective new option.
"Frontpro chewable tablets provide effective protection from fleas and ticks, while complementing the regular care and advice pet owners receive from their veterinarians."
www.uk.frontline.com
The current strain of bluetongue emerged in the Netherlands in 2023 and spread rapidly, infecting over 5,000 livestock farms.
Infection of livestock with this serotype of the virus can result in severe clinical signs and high mortality rates1, significantly impacting animal health, and farming communities.
Bultavo 3 is an inactivated injectable vaccine indicated for the active immunisation against BTV-3.
Boehringer says that in sheep, Bultavo 3 has been shown to significantly reduce viraemia and prevent mortality and clinical signs associated with BTV-3 infection.
Onset of immunity occurs three weeks after administration of a single 1ml subcutaneous dose in sheep.
In cattle, two 1ml intramuscular doses are required, at a three-week interval.
Findlay MacBean, Head of Livestock, UK and Ireland at Boehringer Ingelheim, said: “It’s great news that we can support farmers and authorities in their fight against bluetongue with our new BTV-3 vaccine, Bultavo 3.
"As we have seen across Europe, and now in the UK, BTV can spread rapidly and causes considerable stress to farmers because of the significant financial impact on those affected.
The availability of Bultavo 3 means future BTV-3 outbreaks can be suppressed, helping farmers protect not only their herds, but also their livelihoods.” Oli Maxwell, BVSc BSc(Hons) MVM DipECBHM, RCVS Recognised Specialist in Cattle Health and Production and Clinical Director of Green Counties Vets said: “Farmers are justifiably concerned about BTV-3 and its incursion into the UK again this year.
"Reports from colleagues on the continent regarding the severity of clinical signs, especially in sheep are worrying.
"We have seen a huge increase in clients asking about the disease, progress on a vaccine and what this may mean for animal movements at a critical time of year.
"The availability of a safe and effective vaccine as a critical tool against a disease that we can’t reasonably prevent with biosecurity measures will be a welcome development for many.”
To manage supply and demand, use of the product will initially be subject to geographical restriction with vaccination permitted in high-risk English counties: Norfolk, Suffolk, Essex, Kent and East Sussex.
Reference:
Each SoundTalks device has a microphone which covers up to a 10-metre radius.
Noises are transmitted to the cloud where sounds are analysed using algorithms which Boehringer says use many years of data, and with the use of AI are constantly evolving.
The company says the device, which monitors coughing 24/7, has already been shown to detect respiratory disease in pigs up to five days sooner than conventional methods, allowing vets and farmers to respond quicker, improving health outcomes, and minimising the risk of infection across the herd. 1,2
Paul Thompson BA VetMB MRCVS from Garth Pig Practice said: “The earlier we can detect the onset of disease the quicker we can intervene.
"By taking action earlier we can aim to reduce morbidity and mortality, and potentially lessen treatments including antibiotic use.
"This will help improve the wellbeing of the pigs and reduce the time commitments and costs for the farmer.
"Having heard how SoundTalks is already transforming the practices of producers and vets in other parts of Europe, I am excited to use it in my own day-to-day role.
"This innovation has the potential to provide robust data as to when respiratory disease starts, allowing us to refine our prevention plans and improve the overall health of the pigs.”
www.soundtalks.com
whatstherisk.co.uk has been created for all practice staff and contains advice from parasitologists Ian Wright and Eric Morgan.
Topics include advice on practical risk assessments, how risk-based prescribing can work with health plans as well as how to get owners involved to make risk assessment and personalised prescribing quicker and simpler.
Boehringer says that all the materials and advice have been developed in line with RCVS Practice Standards and the BVA's guidance on the responsible use of parasiticides.1,2
Sharron Woods, NexGard brands Franchise Manager said: “With knowledge about parasitic risk low among dog owners, alongside increasing scrutiny on the potential overuse of parasiticides, we’re delighted to be at the forefront of supporting vets, pet owners and the wider industry in driving best-practice risk assessment and responsible parasite control."
Boehringer says Senvelgo controls blood sugar levels usually within a week1,2 without the risk of symptomatic hypoglycaemia and without the need for twice daily insulin injections.
Studies have shown that around 1 in 200 cats develop diabetes4,5 - somewhere around 55,000 in the UK - of which 20% are euthanased within a year: 10% because of owners not wanting to inject with insulin, and a further 10% because of lack of success or compliance with insulin.3
This new treatment, with its once-daily oral treatment regime and simple dosing according to bodyweight, could have a significant impact on those numbers.
On top of which, there's no need for glucose curves to determine dosage, it's easily stored and doesn't need refrigeration, and it creates less waste than insulin (1 reusable oral syringe vs 180 insulin syringes).
Samantha Taylor BVetMed(Hons) CertSAM DipECVIM-CA MANZCVS FRCVS said: "This is the development in diabetes management we have been waiting many years for; a practical oral therapy to treat this challenging disease.”
To support vet professionals with using Senvelgo, Boehringer has produced a toolkit that includes a veterinary management guide, CPD webinar, cat owner leaflet and homecare journal, along with websites for vets and cat owners.
www.senvelgo.co.uk
Although the disease is commonly diagnosed later in life, a 2022 study of 123 dogs found that 40% of those aged between one and four years old had radiographic osteoarthritis, of which about half had clinical signs and of those only 2 were being treated for pain1.
Another 2022 study found that 38% of dogs over the age of one had osteoarthritic pain, but only half of them were presented for lameness or stiffness2.
Geoffrey Guyot, Pain and Inflammation Franchise Lead at Boehringer Ingelheim Animal Health, said: “Clinical signs of early osteoarthritis can be subtle.
"Some young dogs may present with overt lameness, but many compensate for years and manage to continue to perform their daily activities.
"Common compensations include gait or posture changes to unload the painful joint, which often go unnoticed.”
Boehringer says the aim of its campaign is to shift the perception of osteoarthritis as an old dog disease, to one which could affect dogs of all ages.
Boehringer also wants the campaign to bridge the gap between vets and dog owners, making it easier for owners to spot the early signs and initiate conversations about the condition.
Geoffrey added: "We hope the Arthritis AWARE campaign will raise awareness of early OA among owners to create more opportunities for you to diagnose and treat dogs with arthritis and improve their outcome.
"We encourage vet practices to join us on the journey so we can help improve dogs’ wellbeing together.”
Vet practices can help spread the word by downloading the Arthritis AWARE campaign pack which includes a waiting room video, a poster, owner-facing leaflets, and social media assets.
www.metacam.co.uk/aware
Broadline was a fipronil-based parasiticide which also contained (S)-methoprene, eprinomectin and praziquantel.
NexGard Combo, on the other hand, contains esafoxolaner together with eprinomectin and praziquantel for worming.
Both products are licensed for use in cats with or at risk from mixed infestations by fleas, ticks, mites cestodes, nematodes.
There's an explainer video about NexGard Combo on the Boehringer Academy website: https://www.boehringer-academy.co.uk/
The partnership includes a minimum donation of £10,000 which the company hopes to bolster with additional volunteering and fundraising support.
Gerard Ensink, Head of Animal Health UK and Ireland at Boehringer Ingelheim said: “We are truly delighted to be supporting StreetVet.
“There is already so much passion for the charity within our company.
"Even before we announced this charity partnership, several of our colleagues have been volunteers with StreetVet in a personal capacity.
"We look forward to supporting StreetVet and believe that together we can make a real difference to individuals and their pets who are experiencing homelessness.”
https://www.streetvet.co.uk
The toolkit includes a 15-minute CPD webinar: ‘How to best use ProZinc to successfully manage diabetes in cats and dogs’, hosted by Dr Jamie Adams BVSc PhD MRCVS, Senior Brand Technical Advisor at Boehringer Ingelheim.
Vets who watch the webinar can enter a competition for a coffee machine for their veterinary practice by answering three questions at the end.
The toolkit also has a diabetes management reference guide covering how to make a confident diagnosis and start treatment with ProZinc, how best to monitor and reassess the patient and how to adjust the dose for optimal control.
There are also glucose curve charts, pet owner guides, home care journals and a link to the ProZinc pet owner website, www.prozinc.co.uk, which contains information to help owners feel confident in managing their pet’s diabetes.
The webinar and toolkit are available from: www.boehringer-academy.co.uk.
The online risk checker, which is available at www.parassess.co.uk, asks pet owners a series of questions to assess their dog's risk from fleas, ticks, lungworm roundworm and tapeworm.
The test, which has been developed with parasitologists, takes a few minutes and appears to produce sensible results (not every test produces a "Danger, high risk, emergency, get to your vet NOW" result, as you might expect if this had been entirely produced bv the marketing department).
The subsequent report can then be shared with the vet to review it and make a treatment decision.
Being online, the test can be taken on a smartphone whilst in the practice waiting room, or on tablet or computer at home.
It might be worth sharing the test with your clients by email or social media, inviting them to book an appointment if their results suggest it is necessary.
To that end, Boehringer Ingelheim has produced a range of communication materials, such as waiting room displays and digital content for web, email, SMS, and social media.
For more information, contact your local Boehringer Ingelheim territory manager or phone 01344 746957 (UK) or 01 291 3985 (Ireland).
Frontline wormer for cats contains praziquantel and pyrantel embonate, and for dogs it also contains febantel.
According to the company, Frontline Wormer is effective agains all types of intestinal worms found in the UK: roundworms, tapeworms, hookworms and whipworms.
It is presented as a palatable tablet which can be given as a treat without food, or mixed with food.
The press release from the company says the new product "gives pet parents an easy way to worm their cats and dogs".
"Pet parents?"
Someone please pass me the sick bag.
If I get one more press release describing cat or dog owners as 'pet parents", so help me god I will turn up at the press office and chain myself - naked - to the photocopying machine in protest.
It's a ghastly, patronising, cloying way to refer to people who own an animal, besides which, if I really was the parent of a pet, I would expect to be serving time at His Majesty's pleasure.
Frontline Wormer is available in packs of two tablets for 3 pet sizes.
As an AVM-GSL-licensed product, it can be sold off the shelf.
A 2021 German study reported the incidence of diarrhoea to be 18.5% and the most common disease observed in almost 14,000 neonatal calves examined on 731 dairy herds1.
Fencovis is indicated for the active immunisation of pregnant heifers and cows in order to stimulate the development of antibodies against bovine rotavirus, bovine coronavirus and E. coli expressing F5 (K99) adhesin and to increase the level of passive immunity of calves against neonatal diarrhoea caused by bovine rotavirus, bovine coronavirus and E. coli expressing F5 (K99) adhesin.
Boehringer says that in calves fed with colostrum and milk from vaccinated cows, these antibodies have been demonstrated to prevent diarrhoea caused by rotavirus and E. coli F5 (K99) adhesin and reduce the incidence and severity of diarrhoea caused by coronavirus.
Viral shedding in calves infected by rotavirus and coronavirus was also reduced by Fencovis.
Findlay MacBean, Business Head Livestock at Boehringer Ingelheim UK & Ireland, said: “We are delighted to announce the launch of Fencovis, the first vaccine that is licensed to prevent calf scour caused by Rotavirus and E. coli F5 (K99), and also reduce the incidence and severity of scour associated with coronavirus infection. ”
Fencovis is a suspension for injection which uses a non-oil adjuvant. It comes in a variety of presentations including a single dose pack.
Reference
Renutend contains primed mesenchymal stem cells (MSCs) which Boehringer says are specifically targeted to reduce scar tissue formation so horses can return to the intended level of performance, with a reduced risk of re-injury1.
According to the company, a single dose decreases scar tissue formation with consistent and proven results 2.
RenuTend is administered by intralesional injection and complements Boehringer Ingelheim’s other equine stem cell product Arti-Cell Forte, which is authorised to treat mild to moderate recurrent lameness associated with non-septic joint inflammation in horses.
RenuTend will be available in September this year.
In the meantime, Boehringer is encouraging veterinary surgeons to register their interest with their BIAH representative or call 01344746960 in order to get updates or product information as soon as it becomes available.
TwistPak bottles have a hygienic interlock at the bottom, which allows them to be connected with a twist, creating one single mixing chamber which fits in all standard vaccination devices.
Currently, freshly mixing two vaccines requires a transfer needle.
Boehringer says the TwistPak bottle simplifies the mixing process while retaining the flexibility of using the products as a monovalent or combined vaccine.
TwistPak was jointly created with the industrial design and product development company DESIGNquadrat and awarded a Red Dot Design Award 2021 in the product design category.
Eva Joras, Global Brand Manager at Boehringer Ingelheim said: “TwistPak revolutionizes how vaccines are mixed.
"The mixing platform combines the best of both worlds: the unparalleled quality and efficacy of freshly mixed vaccines with the convenience of ready-to-use solutions.
TwistPak will be globally available in all registered presentation sizes starting May this year.
Trodax is used to treat the mature and late-immature stages of the liver fluke Fasciola hepatica in both cattle and sheep. It is also indicated for the treatment of Haemonchus contortus infections.
Findlay MacBean, Business Head for Ruminant, at Boehringer Ingelheim Animal Health said: “Manufacturing problems have led to Trodax being out of stock since late 2020 and it is with regret that we have to confirm that we are no longer able to manufacture the product.
"As one of the largest animal health businesses in the world we are committed to improving the lives and health of animals. We have a strong research and development focus, and a pipeline of potential products, including antiparasitics. We recognise that the discontinuation of Trodax may pose challenges for cattle and sheep producers where resistance to other flukicides has been confirmed.
“Our technical services team are on hand to support veterinary practice and animal health merchant customers as we make this change to our portfolio. Customers who have a technical enquiry should call 01344 746957 or email vetenquiries@boehringer-ingelheim.com.”
Boehringer says that its other wormer and flukicide brands are not affected and that Ivomec Super Injection, which contains ivermectin and clorsulon, provides an alternative treatment option for adult liver fluke in cattle and is also effective against gastrointestinal worm species, lungworm, and key external parasites.
NexGard Combo is a systemic isoxazoline-based endectocide designed specifically for cats which contains esafoxolaner, eprinomectin and praziquantel.
The new product provides one month’s protection against fleas and five week's protection against the most common tick on cats, Ixodes ricinus. It also treats the roundworms, Toxocara cati and Toxascaris leonina, hookworms, tapeworms and ear mites, against the last of which Nexgard Combo provides 97.2 to 99.9% efficacy following one treatment1.
NexGard Combo can be used in kittens from eight weeks of age and 0.8 kg in weight, making it suitable for most kittens at first vaccination. It is available in two pack sizes: small, for kittens weighing 0.8 - 2.5kg and large, for adult cats weighing 2.5 - 7.5kg. For cats weighing 7.5kg or over, an appropriate combination of applicators should be used.
Jackie Sterratt, senior brand manager at Boehringer Ingelheim, said: “We’re excited to add to the successful NexGard range and to help vets treat more cats. We know only one in two cats is treated for fleas2 and cats are only wormed on average three times per year3 despite all cats being at risk of fleas and most cats requiring monthly roundworming treatment2, 3, so there is a big opportunity to increase treatment rates and compliance. As the only product on the market to treat fleas, ticks, ear mites, roundworms and tapeworms, NexGard Combo offers a simple solution for cats at risk of multiple parasites."
To support the launch Boehringer has produced a marketing package which includes a kitten support pack, client leaflets, dispensing envelope and parasite risk checker.
For further information, contact your local Boehringer Ingelheim territory manager or phone 01344 746957 (UK) or 01 291 3985 (Ireland).
The company points to research which found that 89% of the veterinary profession wants to play a more active role in the sustainability agenda1.
For that reason, Boehringer says it put sustainability at the heart of Aservo EquiHaler, which uses no propellant gasses and the container for which is made from up to 50% recycled materials.
Now Boehringer has launched the first recycling programme for a prescription medicine in the UK to support the responsible disposal of the Aservo EquiHaler.
To join the programme, you need to visit: https://equihaler.uk/recycling, set up a TerraCycle account and register your practice. Boehringer says it only takes 10 minutes.
Once signed-up, a Boehringer Ingelheim Territory Manager will arrange for a collection box to be delivered, along with supporting practice display posters. When the box is full, there is a free pick-up service.
Practices that sign-up for the programme before 31st July 2021 will be entered into a prize draw, with the chance to win a year’s supply of ethically-sourced chocolate for their practice.
The campaign came after the company surveyed livestock farmers in January, February and March this year, and found that cattle producers are struggling to implement changes.
The survey, which received 190 responses, investigated the extent to which beef and dairy producers are aware of methods to sustainably control parasites, how many are following best practice techniques, and what advice and support they need to make a change.
Sioned Timothy, Ruminant Technical Manager at Boehringer Ingelheim Animal Health said: “Reassuringly, 70% of respondents who are the main decision maker indicated that they were either very concerned or a little concerned about wormer resistance on farm. This level of awareness is positive since wormer resistance is on the rise, and the livestock industry must make changes to parasite control if we are to safeguard the effectiveness of wormers."
However, the survey indicated that farmers are not asking professionals such as their vet or SQP for advice on parasite control as much as they could. Only 55% of main decision maker respondents asked their vet for advice on parasite control planning as part of overall herd health planning, and that dropped to 21% for specific parasite control advice.
In addition, only 65% of main decision makers sought advice from an SQP when purchasing worming or fluke products, despite SQPs being qualified to provide parasite control advice at the point of prescription and supply.
Positively, over 60% of main decision maker respondents had already implemented some methods of sustainable parasite control, including quarantining and treating bought-in animals, managing pasture use, and calibrating and testing dosing guns.
However, more than half of the same respondents were aware of but had not implemented several other methods, including weighing or tracking growth rates of youngstock, testing individuals or groups of animals for parasites, and using preventative methods such as vaccinating for lungworm.
Sioned pointed out that nearly 25% of main decision makers had not implemented the calibration or testing of their wormer dosing guns, and a further 12% were not even aware of the practice. She said: “These producers are missing a simple opportunity to ensure that their cattle are dosed correctly. Under-dosing is one of the factors that drives resistance to anthelmintics on farm, and over-dosing increases costs unnecessarily.”
When respondents were asked why they haven’t implemented changes to their parasite control methods, 22% said they did not believe they needed to make changes, 20% don't have the necessary equipment or buildings, 37% said the cost of installing new/better equipment was a barrier, and 32% cited the cost of additional diagnostic tests or treatments.
The survey did highlight some positives. Victoria Hudson, Senior Brand Manager at Boehringer Ingelheim Animal Health, said: “Respondents indicated a good appetite for change provided they could access the appropriate advice and support, including implementing weighing and tracking growth rates of youngstock (53%), testing for parasite burdens in individual animals (52%) and testing for parasite burdens in groups of animals (43%).
“Just over a third of respondents felt they might be able to quarantine and treat bought-in cattle, manage pasture, and use vaccination or other preventative measures. However, only 31% of main decision maker respondents felt they could make the easiest and simplest change: calibrating and testing dosing guns before use.”
One method of sustainable parasite control, targeted selective treatment, where the best performing animals in a group are left untreated, was not well understood or implemented by respondents (30% had implemented, 36% were aware of it but had not implemented, and 33% were not aware of it), and just under 35% felt that even with advice and support they would not be able to implement this method within the next three years.
Victoria said: “Unsurprisingly, over half of main decision maker respondents cited they needed funding to support new equipment/infrastructure to help them make changes to their parasite control practices, but there is a desire for more advice and support.
“Nearly 49% want help in understanding the parasite challenges on their farm, 54% want advice on which changes will most benefit their cattle, and just over 33% want more information on the different types of wormer products.
“However, survey results were conflicting on how farmers would get this advice and support since only 13% wanted more visits from their vet, and 11% from their SQP, despite these professionals being best placed to provide advice at an individual farm level.
“It shows that there is more work to do to help beef and dairy producers make the most effective and sustainable changes to parasite control. This is why we have launched Change One Thing, a campaign to support farmers in understanding and implementing the options available to improve the sustainable control of parasites.”
The campaign is also calling on farm vets to Change One Thing, relating to the information, support and advice that they give livestock farmers.
Victoria said: “It can be difficult for vets to have conversations with farmers about making changes to their parasite control practices, so we urge them to think about changing their approach to discussing the topic, especially if their client/customer has so far resisted making any changes.
“Being inquisitive, and asking questions, can be more effective than ‘telling’, and it’s important that farmers believe in the need to make the change, and that they can practically do it. Even small changes can make a big difference, and testing and trailing strategies tailored to an individual farm will help the farmer to see the benefits for themselves.”
Boehringer says that changes that farmers could make to improve their parasite control in a sustainable way, include:
Resources for farmers, vets and SQPs to Change One Thing are available on the Beat the Parasites website: www.beattheparasites.com/change-one-thing.
Prevexxion RN is composed of a serotype-1 construct vaccine which Boehringer says offers a unique balance between safety and efficacy against the most virulent types of Marek’s disease virus strains.
Prevexxion RN+HVT+IBD is a solution combining Prevexxion RN and Vaxxitek HVT+IBD in one ampoule. It is designed to meet the needs of customers in long-life bird segments with protection from the hatchery.
Prevexxion RN vaccines are available in ampoules of 1000, 2000, and 4000 doses, frozen in liquid nitrogen.
Jerôme Baudon, Head of Poultry at Boehringer Ingelheim, said: “Our Prevexxion RN range provides value through innovation to Marek sensitive poultry producers looking for continuous live production productivity improvement and effective protection. Field and lab experiments conducted worldwide demonstrated its safety, efficacy and its strong, early, and long-lasting protection through the lifespan of the birds and against very virulent Marek’s disease challenge.
Prevexxion RN is the new golden standard for Marek's disease vaccination programs2”.
For more information, contact your Boehringer Ingelheim representative.
The company says that by encouraging socialisation, natural behaviour and good health practices, the campaign will help puppy owners get their journey off to a good start and, with their vet, raise a dog that is healthy and family friendly.
The initiative comprises a range of practice materials, including health advice, training and behaviour tips, and a new owner video covering the essentials of puppy ownership.
The materials include digital content to use in email campaigns and on practice websites and social media channels.
Further support on how to optimise social media channels is also available to practices through PetNatter – Boehringer's free veterinary resource designed to help practices make the most of the opportunities social media provides.
Evelyn Murphy, senior brand manager for NexGard Spectra, said: “The ‘Relax, it’s a Puppy Thing’ initiative is a breath of fresh air and will provide puppy owners with just what they need to help them nurture a puppy through its formative life-stage, while easily and effectively supporting practices in communicating with owners on puppy health and welfare.”
For further information, contact your Boehringer Ingelheim territory manager.
The company says the series will help practices set-up, post content and measure the effectiveness of their social media channels.
There are three introductory videos titled: ‘What are the benefits and why is social media key to my practice?’, ‘Measurement, maintenance and management’ and ‘Planning’.
The first video covers a back-to-basics introduction to social media channels, including Facebook and Instagram. The second video explains how to measure the success of social channels and how to manage posts and content. The final video covers the importance of planning and the use of content calendars to highlight events and awareness days, as well as helpful tools and features such as Facebook Live.
The four how-to guides explain:
The social media videos and how-to guides are part of PetNatter, Boehringer Ingelheim’s free veterinary resource, designed to help veterinary practices stay in touch with owners and help them care for their pets. Originally launched in mid-July, PetNatter provides veterinary practices with professionally crafted social media, newsletter and website content.
Grace Tonner, territory manager at Boehringer Ingelheim said: “Social media plays a big part in our social lives and it is an increasingly important channel in business communities too, which has the potential to help practices maintain and develop vital relationships with pet owners.
"While most vet practices recognise that social media should play an important role in starting and maintaining communications with clients and potential clients, particularly during challenging times such as the COVID-19 pandemic, finding the time, resource and skills to be effective with social media can be challenging.
"Our brilliant series of short, easy-to-understand social media videos and how-to guides provides veterinary professionals with the essential knowledge, tools and confidence to make vet practice social media a hit. Using the videos and guides will enable vet practices to get their social media up and running in just 15 minutes.”
For further information on the social media videos and how-to guides contact your local Boehringer Ingelheim territory manager or visit petnatter.co.uk/how-to.
The company is encouraging owners to post a simple 'thank you' on Facebook with the hashtag #thankuvets.
Boehringer has also produced a thank you video, depicting a day in the life of an equine vet during these tough times.
Warren Ball, Equine Brand Manager at Boehringer Ingelheim Animal Health, said: “This year has been a year like no other, but equine vets throughout the country have carried on regardless of the challenges they face and are deserving of a huge thanks from all who need them.”
"Our ‘Thank You Vets’ initiative will show how appreciated each and every vet is by bringing together owners, trainers and others in the equine community."
To watch the video and see the thank you messages from owners, visit: https://www.facebook.com/equitopmyoplast/posts/2188633904615007
What a lovely initiative. Makes a change from the usual griping on Facebook.